Single room Mevion S250 at Ackerman Cancer Center treats 526 patients with proton therapy in two years

Single room Mevion S250 at Ackerman Cancer Center treats 526 patients with proton therapy in two years

Press releases may be edited for formatting or style | May 09, 2017 Rad Oncology Proton Therapy

Mevion invented the compact proton therapy system to help increase access to this valuable therapy. Mevion currently has more compact systems treating patients than any other proton therapy manufacturer, with 100% of Mevion clinical sites achieving 100% of their financial objectives in the first year.


About Mevion Medical Systems

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs


Mevion Medical Systems, Inc. is a leading provider of compact proton therapy systems for cancer care. Mevion is based in Littleton, Massachusetts, with international offices in Europe, Japan and China. For more information, please visit www.mevion.com.


About the MEVION S250 Series
The MEVION S250 Series offers the smallest, most advanced proton therapy solution available today. Its unique gantry-mounted proton accelerator provides superior treatment delivery, reduces complexity and cost, and significantly streamlines operations. No other proton therapy system can match the quality, size, cost and efficiency of the MEVION S250 Series.

The MEVION S250 Series includes:

· MEVION S250 Proton Therapy System®, offering highly stable, next-generation volumetric delivery capabilities

· MEVION S250i Proton Therapy System™ with HYPERSCAN™ with Adaptive Aperture™, overcoming pencil beam scanning uncertainties by delivering robust IMPT treatment at hyper-speed

· MEVION S250mx™, making proton therapy fully scalable, with two, three and four room designs that are inherently redundant and support 100% facility uptime


The MEVION S250i Proton Therapy System with HYPERSCAN with Adaptive Aperture is not yet FDA cleared.

Back to HCB News

You Must Be Logged In To Post A Comment